normeperidine has been researched along with prazosin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bendesky, R; Broten, TP; Chang, RS; Chen, TB; Chiu, G; Forray, C; Harrell, CM; Lagu, B; Marzabadi, MR; Miao, SW; Murali Dhar, TG; Nagarathnam, D; O'Malley, S; Ransom, R; Schneck, K; Schorn, TW; Shen, Q; Sun, W; Tian, D; Tyagarajan, S; Vyas, KP; Wetzel, JM; Wong, WC; Zhang, F; Zhang, J | 1 |
1 other study(ies) available for normeperidine and prazosin
| Article | Year |
|---|---|
Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Biological Availability; Blood Pressure; Dogs; Drug Design; Drug Evaluation, Preclinical; GTP-Binding Proteins; Half-Life; Humans; In Vitro Techniques; Male; Microsomes; Piperidines; Prostate; Pyrimidinones; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Receptors, Opioid, mu; Recombinant Proteins; Stereoisomerism; Structure-Activity Relationship; Urethra | 1999 |